Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure... see more

Recent & Breaking News (TSX:PRN)

Profound Medical Annual and Special Meeting of Shareholders Voting Results

GlobeNewswire June 13, 2019

Profound Medical Announces First Quarter 2019 Financial Results

GlobeNewswire May 6, 2019

Profound Medical to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 23, 2019

Profound Medical to Release First Quarter 2019 Financial Results on May 6 - Conference Call to Follow

GlobeNewswire April 17, 2019

Foundation Chairman Shares Focused Ultrasound Growth at Inaugural Global Investor Conference

PR Newswire April 15, 2019

Profound Medical Analyst & Investor Day Agenda

GlobeNewswire April 8, 2019

Profound Medical Announces Positive Topline Results from TACT Pivotal Clinical Trial of TULSA-PRO® in Patients with Prostate Cancer

GlobeNewswire April 4, 2019

Profound Medical Announces Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire March 7, 2019

Profound Medical to Present at the Cowen and Company 39th Annual Health Care Conference

GlobeNewswire March 5, 2019

Save the Date: Profound Medical to Host Inaugural Analyst & Investor Day on April 11

GlobeNewswire February 28, 2019

Profound Medical to Release Fourth Quarter and Full Year 2018 Financial Results on March 7 – Conference Call to Follow

GlobeNewswire February 21, 2019

Profound Medical to Participate in the 2019 BTIG MedTech, Life Science & Diagnostic Tools Conference

GlobeNewswire February 20, 2019

Profound Medical Announces Preliminary Unaudited Fourth Quarter 2018 Revenues

GlobeNewswire January 3, 2019

Profound Medical Announces Changes to Commercial Organization

GlobeNewswire December 14, 2018

Profound Medical Announces Third Quarter 2018 Financial Results

GlobeNewswire November 8, 2018

Profound Medical to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Accesswire November 8, 2018

Profound Medical to Present at the Stifel 2018 Healthcare Conference

GlobeNewswire November 7, 2018

Profound Medical to Release Third Quarter 2018 Financial Results on November 8 – Conference Call to Follow

GlobeNewswire October 30, 2018

3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018

GlobeNewswire September 18, 2018

Profound Medical Files Preliminary Base Shelf Prospectus

GlobeNewswire September 6, 2018